Reaction Details |
| Report a problem with these data |
Target | C-C chemokine receptor type 3 |
---|
Ligand | BDBM50264157 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_535295 (CHEMBL982620) |
---|
IC50 | 23±n/a nM |
---|
Citation | Sato, I; Morihira, K; Inami, H; Kubota, H; Morokata, T; Suzuki, K; Iura, Y; Nitta, A; Imaoka, T; Takahashi, T; Takeuchi, M; Ohta, M; Tsukamoto, S Design and synthesis of 6-fluoro-2-naphthyl derivatives as novel CCR3 antagonists with reduced CYP2D6 inhibition. Bioorg Med Chem16:8607-18 (2008) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
C-C chemokine receptor type 3 |
---|
Name: | C-C chemokine receptor type 3 |
Synonyms: | C-C CKR-3 | C-C chemokine receptor type 3 (CCR3) | CC-CKR-3 | CCR-3 | CCR3 | CCR3_HUMAN | CD_antigen=CD193 | CKR3 | CMKBR3 | Eosinophil eotaxin receptor |
Type: | Enzyme |
Mol. Mass.: | 41053.88 |
Organism: | Homo sapiens (Human) |
Description: | P51677 |
Residue: | 355 |
Sequence: | MTTSLDTVETFGTTSYYDDVGLLCEKADTRALMAQFVPPLYSLVFTVGLLGNVVVVMILI
KYRRLRIMTNIYLLNLAISDLLFLVTLPFWIHYVRGHNWVFGHGMCKLLSGFYHTGLYSE
IFFIILLTIDRYLAIVHAVFALRARTVTFGVITSIVTWGLAVLAALPEFIFYETEELFEE
TLCSALYPEDTVYSWRHFHTLRMTIFCLVLPLLVMAICYTGIIKTLLRCPSKKKYKAIRL
IFVIMAVFFIFWTPYNVAILLSSYQSILFGNDCERSKHLDLVMLVTEVIAYSHCCMNPVI
YAFVGERFRKYLRHFFHRHLLMHLGRYIPFLPSEKLERTSSVSPSTAEPELSIVF
|
|
|
BDBM50264157 |
---|
n/a |
---|
Name | BDBM50264157 |
Synonyms: | CHEMBL519750 | N-{(3-exo)-8-[(6-Fluoro-2-naphthyl)methyl]-8-azabicyclo[3.2.1]oct-3-yl}-2-(piperidin-1-ylcarbonyl)benzamide |
Type | Small organic molecule |
Emp. Form. | C31H34FN3O2 |
Mol. Mass. | 499.619 |
SMILES | Fc1ccc2cc(CN3[C@@H]4CC[C@@H]3CC(C4)NC(=O)c3ccccc3C(=O)N3CCCCC3)ccc2c1 |r,TLB:7:8:14.15.13:10.11,THB:16:14:8:10.11| |
Structure |
|